INSMED INC Proceeds from Issuance of Debt
INSMED INC (INSM) reported Proceeds from Issuance of Debt of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2019-02-22
- INSMED INC proceeds from issuance of debt for the quarter ending 2018-12-31 was -$450.00M.
- INSMED INC proceeds from issuance of debt for the quarter ending 2018-09-30 was $0.00.
- INSMED INC proceeds from issuance of debt for the quarter ending 2018-06-30 was $0.00.
- INSMED INC proceeds from issuance of debt for the quarter ending 2018-03-31 was $450.00M.
- INSMED INC proceeds from issuance of debt for fiscal 2018 was $0.00.
- INSMED INC proceeds from issuance of debt for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- INSMED INC proceeds from issuance of debt for fiscal 2016 was $30.00M.
- INSMED INC proceeds from issuance of debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$450.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$450.00M derived: sum of 2 quarters · filed 2019-02-22 | -$450.00M derived: sum of 3 quarters · filed 2019-02-22 | $0.00 10-K · filed 2019-02-22 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $450.00M 10-Q · filed 2018-10-30 | $450.00M derived: sum of 4 quarters · filed 2019-02-22 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $450.00M 10-Q · filed 2018-08-02 | $450.00M derived: sum of 3 quarters · filed 2019-02-22 | $450.00M derived: sum of 4 quarters · filed 2019-02-22 |
| 2018-03-31 | $450.00M 10-Q · filed 2018-05-02 | $450.00M derived: sum of 2 quarters · filed 2019-02-22 | $450.00M derived: sum of 3 quarters · filed 2019-02-22 | $450.00M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $0.00 derived: sum of 2 quarters · filed 2019-02-22 | $0.00 derived: sum of 3 quarters · filed 2019-02-22 | $0.00 10-K · filed 2019-02-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | $20.00M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | $20.00M derived: sum of 3 quarters · filed 2019-02-22 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | $20.00M derived: sum of 2 quarters · filed 2019-02-22 | ||
| 2016-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $30.00M 10-K · filed 2019-02-22 | ||
| 2016-09-30 | $10.00M 10-Q · filed 2017-11-02 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-23 | |||
| 2014-12-31 | $5.00M 10-K · filed 2017-02-23 | |||
| 2012-12-31 | $20.00M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |